メインナビゲーションにスキップ 検索にスキップ メインコンテンツにスキップ

Encephalitogenic peptide (EP) in human cerebrovascular white matter lesions

  • Hidekazu Tomimoto
  • , Ichiro Akiguchi
  • , Akinori Matsuo
  • , Kazuhiro Terai
  • , Hideaki Wakita
  • , Jun Kimura
  • , P. L. McGeer
  • , Herbert Budka

研究成果: ジャーナルへの寄稿学術論文査読

抄録

THE expression of encephalitogenic peptide (EP), a 68-86 amino acid sequence of guinea pig myelin basic protein (MBP), was investigated in autopsied brains with focal cerebral damage or with diffuse white matter (WM) lesions. EP immunoreactive fibers were distributed in parallel with fibers immunoreactive for amyloid protein precursor (APP), an indicator of WM damages. EP was expressed in the periphery of cerebral infarctions and hematoma in the acute and subacute stages, but was also distributed in diffuse WM lesions due to heterogeneous causes. These data indicate that EP epitopes are exposed specifically in ongoing WM damages, and that the destruction of myelin occurs sporadically in diffuse WM lesions of varying intensity.

本文言語英語
ページ(範囲)3727-3730
ページ数4
ジャーナルNeuroreport
8
17
DOI
出版ステータス出版済み - 1997
外部発表はい

All Science Journal Classification (ASJC) codes

  • 神経科学一般

フィンガープリント

「Encephalitogenic peptide (EP) in human cerebrovascular white matter lesions」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル